会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Mesenchymal stem cells produced from human pluripotent stem cells
    • 由人多能干细胞产生的间充质干细胞
    • US09388384B2
    • 2016-07-12
    • US13504881
    • 2009-10-28
    • Hyo Soo KimHyun Jae KangEun Ju LeeYoung Bae Park
    • Hyo Soo KimHyun Jae KangEun Ju LeeYoung Bae Park
    • C12N5/00C12N5/0775A61K35/48
    • C12N5/0662A61K35/48C12N2500/38C12N2501/105C12N2501/11C12N2501/115C12N2501/155C12N2501/165C12N2501/39C12N2506/02
    • Provided is a method for producing mesenchymal stem cells from human pluripotent stem cells, the method including: a) forming embryonic bodies from human pluripotent stem cells; b) attaching the embryonic bodies to a culture dish to induce natural differentiation of the embryonic bodies into mesenchymal stem cells; and c) performing continuous proliferative culturing of the mesenchymal stem cells while still maintaining the identity of the mesenchymal stem cells. Also, provided is a standardized method for inducing differentiation of mesenchymal stem cells, which can be broadly applied to all human pluripotent stem cells regardless of a difference in the genetic background thereof. Ultimately, the present invention can continuously mass-produces the mesenchymal stem cells necessary for regenerative medicine and cell therapy by using human pluripotent stem cells, thereby realizing practical uses of cell therapy products, and further the present invention is expected to highly contribute to treatments of incurable diseases, such as cardiovascular diseases and neurological disorders.
    • 提供一种从人多能干细胞产生间充质干细胞的方法,所述方法包括:a)从人多能干细胞形成胚体; b)将胚胎体附着到培养皿中以诱导胚胎体自然分化成间充质干细胞; 和c)对间充质干细胞进行连续增殖培养,同时仍保持间充质干细胞的特性。 此外,提供了诱导间充质干细胞分化的标准化方法,其可以广泛地应用于所有人多能干细胞,而与其遗传背景的差异无关。 最终,本发明可以通过使用人多能干细胞连续批量生产再生医学和细胞治疗所需的间充质干细胞,从而实现细胞治疗产品的实际应用,并且进一步预期本发明对 不治之症,如心血管疾病和神经系统疾病。
    • 4. 发明申请
    • METHOD FOR PRODUCING MESENCHYMAL STEM CELLS FROM HUMAN PLURIPOTENT STEM CELLS, AND MESENCHYMAL STEM CELLS PRODUCED BY SAME
    • 用于从人源性干细胞生产间充质干细胞的方法和由其生产的骨髓干细胞
    • US20120276625A1
    • 2012-11-01
    • US13504881
    • 2009-10-28
    • Hyo Soo KimHyun Jae KangEun Ju LeeYoung Bae Park
    • Hyo Soo KimHyun Jae KangEun Ju LeeYoung Bae Park
    • C12N5/0775
    • C12N5/0662A61K35/48C12N2500/38C12N2501/105C12N2501/11C12N2501/115C12N2501/155C12N2501/165C12N2501/39C12N2506/02
    • Provided is a method for producing mesenchymal stem cells from human pluripotent stem cells, the method including: a) forming embryonic bodies from human pluripotent stem cells; b) attaching the embryonic bodies to a culture dish to induce natural differentiation of the embryonic bodies into mesenchymal stem cells; and c) performing continuous proliferative culturing of the mesenchymal stem cells while still maintaining the identity of the mesenchymal stem cells. Also, provided is a standardized method for inducing differentiation of mesenchymal stem cells, which can be broadly applied to all human pluripotent stem cells regardless of a difference in the genetic background thereof. Ultimately, the present invention can continuously mass-produces the mesenchymal stem cells necessary for regenerative medicine and cell therapy by using human pluripotent stem cells, thereby realizing practical uses of cell therapy products, and further the present invention is expected to highly contribute to treatments of incurable diseases, such as cardiovascular diseases and neurological disorders.
    • 提供一种从人多能干细胞产生间充质干细胞的方法,所述方法包括:a)从人多能干细胞形成胚体; b)将胚胎体附着到培养皿中以诱导胚胎体自然分化成间充质干细胞; 和c)对间充质干细胞进行连续增殖培养,同时仍保持间充质干细胞的特性。 此外,提供了诱导间充质干细胞分化的标准化方法,其可以广泛地应用于所有人多能干细胞,而与其遗传背景的差异无关。 最终,本发明可以通过使用人多能干细胞连续批量生产再生医学和细胞治疗所需的间充质干细胞,从而实现细胞治疗产品的实际应用,并且进一步预期本发明对 不治之症,如心血管疾病和神经系统疾病。